3Robert PC, James KD. Risk-based Quality by Design (QbD) :ATaguchi perspective on the assessment of product quality, and the quantitative linkage of drug product param- eters and clinical performance [ J ]. Pharm Innov , 2008,3 ( 1 ) :23-29.
4U. S. Department of Health and Human Services Food and Drug Administration. Guidance for industry Q8 pharmaceu- tical development [ EB/OL]. (2006-05) [ 2013-01-14 ]. http ://www. fda. gov /downloads /RegulatoryInformation /Guidances/ucm128029. pdf.
